Fat and cardiotoxicity in hereditary pulmonary hypertension.
作者信息
Tuder Rubin M, Robinson Jeffrey C, Graham Brian B
机构信息
1 Division of Pulmonary Sciences and Critical Care Medicine University of Colorado School of Medicine Aurora, Colorado.
出版信息
Am J Respir Crit Care Med. 2014 Feb 1;189(3):247-9. doi: 10.1164/rccm.201312-2240ED.
Abstract
摘要
相似文献
1
Fat and cardiotoxicity in hereditary pulmonary hypertension.
Am J Respir Crit Care Med. 2014 Feb 1;189(3):247-9. doi: 10.1164/rccm.201312-2240ED.
2
Evidence for right ventricular lipotoxicity in heritable pulmonary arterial hypertension.
Am J Respir Crit Care Med. 2014 Feb 1;189(3):325-34. doi: 10.1164/rccm.201306-1086OC.
3
Pre-implantation genetic testing for hereditary pulmonary arterial hypertension: promise and caution.
Eur Respir J. 2012 Jun;39(6):1292-3. doi: 10.1183/09031936.00218911.
4
Waiting in anticipation: the genetics of pulmonary arterial hypertension.
Am J Respir Crit Care Med. 2012 Nov 1;186(9):820-1. doi: 10.1164/rccm.201209-1666ED.
5
Letter by Kataoka et al Regarding Article, "Bone Morphogenetic Protein Receptor Type 2 Mutation in Pulmonary Arterial Hypertension: A View on the Right Ventricle".
Circulation. 2016 Aug 30;134(9):e115-6. doi: 10.1161/CIRCULATIONAHA.116.022841.
6
Response by van der Bruggen et al to Letter Regarding Article, "Bone Morphogenetic Protein Receptor Type 2 Mutation in Pulmonary Arterial Hypertension: A View on the Right Ventricle".
Circulation. 2016 Aug 30;134(9):e117-8. doi: 10.1161/CIRCULATIONAHA.116.024173.
7
Understanding the low penetrance of bone morphogenetic protein receptor 2 gene mutations: another needle in the haystack.
Circulation. 2012 Oct 9;126(15):1818-20. doi: 10.1161/CIRCULATIONAHA.112.135004.
8
Heritable pulmonary arterial hypertension with elevated pulmonary wedge pressure.
Circulation. 2012 Aug 28;126(9):e124-7. doi: 10.1161/CIRCULATIONAHA.112.096271.
9
MicroRNA-424(322) as a new marker of disease progression in pulmonary arterial hypertension and its role in right ventricular hypertrophy by targeting SMURF1.
Cardiovasc Res. 2018 Jan 1;114(1):53-64. doi: 10.1093/cvr/cvx187.
10
Bone Morphogenetic Protein Receptor Type 2 Mutation in Pulmonary Arterial Hypertension: A View on the Right Ventricle.
Circulation. 2016 May 3;133(18):1747-60. doi: 10.1161/CIRCULATIONAHA.115.020696. Epub 2016 Mar 16.
引用本文的文献
1
Pulmonary Hypertension and Right Ventricle: A Pathophysiological Insight.
Clin Med Insights Cardiol. 2024 Sep 9;18:11795468241274744. doi: 10.1177/11795468241274744. eCollection 2024.
2
Molecular mechanisms of right ventricular dysfunction in pulmonary arterial hypertension: focus on the coronary vasculature, sex hormones, and glucose/lipid metabolism.
Cardiovasc Diagn Ther. 2020 Oct;10(5):1522-1540. doi: 10.21037/cdt-20-404.
3
Role of oxidized lipids in pulmonary arterial hypertension.
Pulm Circ. 2016 Sep;6(3):261-73. doi: 10.1086/687293.
4
Update in Pulmonary Vascular Diseases 2014.
Am J Respir Crit Care Med. 2015 Sep 1;192(5):544-50. doi: 10.1164/rccm.201504-0829up.
本文引用的文献
1
Evidence for right ventricular lipotoxicity in heritable pulmonary arterial hypertension.
Am J Respir Crit Care Med. 2014 Feb 1;189(3):325-34. doi: 10.1164/rccm.201306-1086OC.
2
Chronic heart failure is associated with transforming growth factor beta-dependent yield and functional decline in atrial explant-derived c-Kit+ cells.
J Am Heart Assoc. 2013 Oct 2;2(5):e000317. doi: 10.1161/JAHA.113.000317.
3
Cardiac lipotoxicity: molecular pathways and therapeutic implications.
Curr Heart Fail Rep. 2013 Jun;10(2):109-21. doi: 10.1007/s11897-013-0133-0.
4
Metabolic gene remodeling and mitochondrial dysfunction in failing right ventricular hypertrophy secondary to pulmonary arterial hypertension.
Circ Heart Fail. 2013 Jan;6(1):136-44. doi: 10.1161/CIRCHEARTFAILURE.111.966127. Epub 2012 Nov 14.
5
Transforming growth factor beta-1 and incidence of heart failure in older adults: the Cardiovascular Health Study.
Cytokine. 2012 Nov;60(2):341-5. doi: 10.1016/j.cyto.2012.07.013. Epub 2012 Aug 9.
6
Lipid metabolism and toxicity in the heart.
Cell Metab. 2012 Jun 6;15(6):805-12. doi: 10.1016/j.cmet.2012.04.006.
7
Modern age pathology of pulmonary arterial hypertension.
Am J Respir Crit Care Med. 2012 Aug 1;186(3):261-72. doi: 10.1164/rccm.201201-0164OC. Epub 2012 Jun 7.
8
Targeting energetic metabolism: a new frontier in the pathogenesis and treatment of pulmonary hypertension.
Am J Respir Crit Care Med. 2012 Feb 1;185(3):260-6. doi: 10.1164/rccm.201108-1536PP. Epub 2011 Nov 10.
9
Mitochondrial metabolic adaptation in right ventricular hypertrophy and failure.
J Mol Med (Berl). 2010 Oct;88(10):1011-20. doi: 10.1007/s00109-010-0679-1. Epub 2010 Sep 4.
10
Fatty acid oxidation and malonyl-CoA decarboxylase in the vascular remodeling of pulmonary hypertension.
Sci Transl Med. 2010 Aug 11;2(44):44ra58. doi: 10.1126/scitranslmed.3001327.
Zotero 插件